SBPLX
Price
$30.00
Change
-$0.12 (-0.40%)
Updated
Jun 22 closing price
Net Assets
9.19B
VSMPX
Price
$336.81
Change
-$1.16 (-0.34%)
Updated
Jun 22 closing price
Net Assets
2.31T
Interact to see
Advertisement

SBPLX vs VSMPX

SBPLX vs VSMPX Comparison Chart in %
View a ticker or compare two or three
VS
SBPLX vs. VSMPX commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SBPLX is a Buy and VSMPX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSMPX has more cash in the bank: 2.31T vs. SBPLX (9.19B). VSMPX pays higher dividends than SBPLX: VSMPX (1.02) vs SBPLX (0.45). SBPLX was incepted earlier than VSMPX: SBPLX (28 years) vs VSMPX (11 years). SBPLX (1.75) is less costly to investors than VSMPX (0.02). SBPLX is a more actively managed with annual turnover of: 30.00 vs. VSMPX (3.00). SBPLX has a lower initial minimum investment than VSMPX: SBPLX (1000) vs VSMPX (100000000). VSMPX annual gain was more profitable for investors over the last year : 26.19 vs. SBPLX (1.92). VSMPX return over 5 years is better than : 68.83 vs. SBPLX (4.90).
SBPLXVSMPXSBPLX / VSMPX
Total Expense Ratio1.750.028,750%
Annual Report Gross Expense Ratio1.750.028,750%
Fund Existence28 years11 years-
Gain YTD5.76410.40155%
Front LoadN/AN/A-
Min. Initial Investment10001000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets9.19B2.31T0%
Annual Yield % from dividends0.451.0244%
Returns for 1 year1.9226.197%
Returns for 3 years11.0272.6715%
Returns for 5 years4.9068.837%
Returns for 10 years60.06258.0423%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FCDIX50.93N/A
N/A
Fidelity Advisor Stock Selector Sm Cp I
DLRHX24.70N/A
N/A
Nomura Healthcare Fund Class R
LCIAX217.63N/A
N/A
SEI Large Cap Index A (SIIT)
FOCIX15.37N/A
N/A
Fairholme Focused Income
NUGIX35.71N/A
N/A
Nuveen Global Dividend Growth I